Avacta shares are approaching 6 month highs, are they still a buy?

Home > Analysis > Avacta (LON:AVCT)

Avacta Life Sciences Group Plc (www.avacta.com) is a small-cap biotech company. Two key divisions support the health company: Oncology drug development (Therapeutics) and Diagnostics. The latter is about expanding the in-vitro diagnostics business to support the medical profession; while the former is about leveraging its proprietary pre|CISION and...

Get unlimited access to the Good Money Guide expert analysis

Become a better, more informed investor with Good Money Guide. Our expert exclusive analysis provides the sort of information that everyone, from first-time investors to experienced professional traders, can learn to profit from.

Monthly

Premium
$ 4
99
Monthly
  • Expert Market Analysis
  • Buy & Sell Ratings
  • Investing Indicators
  • Educational Courses
  • Exclusive Event Invites
  • Broker Comparison

Yearly

Premium
$ 49 Yearly
  • Save 15%
  • 14-Day Money Back Guarantee
  • Expert Market Analysis
  • Buy & Sell Ratings
  • Investing Indicators
  • Educational Courses
  • Exclusive Event Invites
  • Broker Comparison
Save 15%

Scroll to Top